Live Breaking News & Updates on Takeda Intends

Stay updated with breaking news from Takeda intends. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab TAK079 a Potential BestinClass AntiCD38 Monoclonal Antibody for Primary Immune Thrombocytopenia

TakedaTSE4502NYSETAK today announced positive topline results from a Phase 2 randomized doubleblind placebocontrolled study evaluating the safety tolerability and efficacy of mezagitamab TAK079 in patients with persistent or chronic primary immune thrombocytopenia ITP. ....

United States , Chinwe Ukomadu , Yuko Yoneyama , Rodeghierof International Journal Of Hematology , Takeda Pharmaceutical Company Limited , Exchange Commission , Development In Fiscal Year , Drug Administration , Efficacy Results , Mezagitamab Safe , Takeda Intends , Global Phase , Primary Immune Thrombocytopenia , Fiscal Year , Late Stage Pipeline Continues , Inflammation Therapeutic Area Unit , Orphan Drug Designation , Fast Track , Annual Report , Media Contact ,

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK279 a Highly Selective Oral TYK2 Inhibitor for the Treatment of Active Psoriatic Arthritis

Takeda TSE4502NYSETAK today announced positive topline results from its randomized doubleblind placebocontrolled multipledose Phase 2b trial evaluating TAK279 an investigational oral allosteric tyrosine kinase 2 TYK2 inhibitor with next generation selectivity in people with active psoriatic arthritis. ....

New Orleans , United States , Mark Dole , Jun Saito , Greenwood Carriero , Takeda Pharmaceuticals , Exchange Commission , American College Of Rheumatology , Takeda Pharmaceutical Company Limited , International Media , American Academy Of Dermatology Annual Meeting , Society For Investigative Dermatology Annual Meeting , Topline Results , Significantly Greater Proportion , Psoriatic Arthritis Patients Achieved , Positive Results , Takeda Intends , Full Clinical Results Will , Upcoming Medical , American College , Andy Plump , Fiscal Year , Psoriasis Area , Severity Index , Tyrosine Kinase , Annual Report ,

Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
businesswireindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswireindia.com Daily Mail and Mail on Sunday newspapers.

United States , Dominican Republic , Sri Lanka , Rachel Wiese , Kazumi Kobayashi , Derek Wallace , Centers For Disease , Takeda Pharmaceutical Company Limited , World Health Organization , Data Monitoring Committee , Takeda Pharmaceutical Company , Exchange Commission , European Medicines Agency To Conduct First , European Union , European Medicines Agency , Natural Resources Defense Council , Dengue Global Program Leader At Takeda , Committee For Medicinal Products Human Use , Conduct First Ever Parallel Assessment , Medicinal Product , Dengue Vaccine Candidate , Countries Outside , Previously Article , Takeda Intends , Submit Regulatory Filings , Thailand During ,